45LOW

IMR

IMRICOR CDI FORUS [IMR]
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Healthcare · ASX Small Cap
$1.9850 +2.3%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical61
Catalyst50
Sentiment50
Fundamental55
Momentum58
Risk Gate45
Get alerts when IMR's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track IMR — Free

Active Signals

Bullish Signals

  • Trading above the 200-day average — the long-term trend is on your side
  • Strong cash runway (9 quarters)
  • Very high P/S ratio (2174.0x)
  • Revenue in sharp decline (-83%)
  • CANSLIM I: Institutional ownership (18%)
  • Sentiment is mixed — no strong consensus either way
  • Positive long-term momentum — up 24% over the past year
  • The bigger volume days are the up days — volume-weighted momentum is positive (1.97%/day)
  • Beneish M-Score -2.07 (grey zone -2.22 to -1.78): possible earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -83% — the top line is shrinking
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about IMR
"What's driving IMR's score?" "How does IMR compare to peers?" "Key risks for IMR?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Form 10 Registration with the U.S. SEC
NONE Imricor Releases FY25 Results
NONE Appendix 4E and FY25 Financial Accounts
LOW FY25 Results Investor Presentation

Recent ASX Announcements

2026-03-18 Form 10 Registration with the U.S. SEC PRICE SENSITIVE
2026-02-24 FY25 Results Investor Presentation PRICE SENSITIVE
2026-02-24 Imricor Releases FY25 Results PRICE SENSITIVE
2026-02-24 Appendix 4E and FY25 Financial Accounts PRICE SENSITIVE
2026-02-17 Na Homolce to Become 3rd Site for VISABL-VT PRICE SENSITIVE

Key Metrics

$635.5M
Market Cap
378K
Avg Volume
1.3x
Vol Ratio
$1.11 — $2.25
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-1221.3%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 86%
LLeader vs LaggardpassRS: 7
IInstitutional SponsorshippassInst: 18%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #69 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:IMR vs ATXIMR vs PNVIMR vs IMM
Scout Pro — Deeper Analysis for IMR
Try Pro free for 30 days
Share this analysis

Track IMR and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required